Company News: Pfizer

Share this article:
Pfizer CEO Jeff Kindler told shareholders that no one Pfizer product "is expected to account for more than 10% of our annual revenue, once Lipitor loses US exclusivity" late next year. Lipitor accounted for 23%, or $11 billion, of the company's annual revenue in 2009. Preliminary voting results on a handful of topics -- excluding stockholders from advising on executive pay, confirming the company's public accounting firm of record (KPMG), confirming company directors and a shrinking of the percent of shares required to hold special shareholder meetings were all passed by large margins. Only one initiative was rejected -- a proposal put forth by Evelyn Y. Davis -- that would have halted the practice of offering executives stock options. The annual shareholders meeting was held in Cleveland.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.

IRS struggles with device tax

A Treasury report says the IRS is having trouble identifying who owes it money.

White House proposes Hobby Lobby alternative

A proposal by the Obama administration Friday seeks to keep contraception accessible and coverage approval at arm's length for employees of religious non-profits.